← Open Payments lookup

JENNIFER O'NEILL: Open Payments

NPI 1063096501 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$724 in 38 payments from 11 companies in 2025. Trend: 2023 $235 · 2024 $921 · 2025 $724

Food & beverage: $724
CompanyPaymentsAmount
QOL Medical, LLC7$160
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$137
Janssen Biotech, Inc.6$115
PFIZER INC.5$93
Takeda Pharmaceuticals U.S.A., Inc.4$81
Aimmune Therapeutics, Inc.2$31
Exact Sciences Corporation1$29
Madrigal Pharmaceuticals1$23
Lilly USA, LLC1$20
Ipsen Biopharmaceuticals, Inc1$19

Products named: Sucraid, XIFAXAN, TREMFYA, ENTYVIO, VELSIPITY, XELJANZ, ZENPEP, Cologuard Collection Kit.

Industry payments across NJ — which companies pay providers there.